---
layout: default
title: Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?
---

# Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2506.10912" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2506.10912v2</a>
  <a href="https://arxiv.org/pdf/2506.10912.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2506.10912v2" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2506.10912v2', 'Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Fei Lin, Ziyang Gong, Cong Wang, Yonglin Tian, Tengchao Zhang, Xue Yang, Gen Luo, Fei-Yue Wang

**åˆ†ç±»**: cs.AI, cs.CL

**å‘å¸ƒæ—¥æœŸ**: 2025-06-12 (æ›´æ–°: 2025-06-18)

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºToxiMolåŸºå‡†ä»¥è§£å†³åˆ†å­æ¯’æ€§ä¿®å¤é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `åˆ†å­æ¯’æ€§ä¿®å¤` `å¤šæ¨¡æ€å¤§è¯­è¨€æ¨¡å‹` `æ¯’æ€§è¯„ä¼°` `æ•°æ®é›†æ„å»º` `è¯ç‰©å¼€å‘`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰çš„åˆ†å­æ¯’æ€§ä¿®å¤æ–¹æ³•ç¼ºä¹ç³»ç»Ÿæ€§å®šä¹‰å’ŒåŸºå‡†ï¼Œå¯¼è‡´è¯ç‰©å¼€å‘ä¸­çš„æ¯’æ€§é—®é¢˜éš¾ä»¥æœ‰æ•ˆè§£å†³ã€‚
2. æœ¬æ–‡æå‡ºäº†ToxiMolåŸºå‡†ä»»åŠ¡ï¼Œæ„å»ºäº†æ¶µç›–å¤šç§æ¯’æ€§æœºåˆ¶çš„æ ‡å‡†åŒ–æ•°æ®é›†ï¼Œå¹¶è®¾è®¡äº†æœºåˆ¶æ„ŸçŸ¥çš„æç¤ºæ³¨é‡Šæµç¨‹ã€‚
3. å®éªŒè¯„ä¼°æ˜¾ç¤ºï¼Œå°½ç®¡å½“å‰MLLMsåœ¨æ¯’æ€§ä¿®å¤ä»»åŠ¡ä¸Šä»é¢ä¸´æŒ‘æˆ˜ï¼Œä½†åœ¨æ¯’æ€§ç†è§£å’Œç»“æ„æ„ŸçŸ¥ç¼–è¾‘æ–¹é¢å±•ç°å‡ºæ½œåŠ›ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

æ¯’æ€§æ˜¯æ—©æœŸè¯ç‰©å¼€å‘å¤±è´¥çš„ä¸»è¦åŸå› ä¹‹ä¸€ã€‚å°½ç®¡åˆ†å­è®¾è®¡å’Œå±æ€§é¢„æµ‹å·²æœ‰æ‰€è¿›å±•ï¼Œä½†åˆ†å­æ¯’æ€§ä¿®å¤è¿™ä¸€ä»»åŠ¡å°šæœªå¾—åˆ°ç³»ç»Ÿå®šä¹‰æˆ–åŸºå‡†åŒ–ã€‚ä¸ºå¡«è¡¥è¿™ä¸€ç©ºç™½ï¼Œæœ¬æ–‡æå‡ºäº†ToxiMolï¼Œè¿™æ˜¯é¦–ä¸ªé’ˆå¯¹å¤šæ¨¡æ€å¤§è¯­è¨€æ¨¡å‹ï¼ˆMLLMsï¼‰åœ¨åˆ†å­æ¯’æ€§ä¿®å¤æ–¹é¢çš„åŸºå‡†ä»»åŠ¡ã€‚æˆ‘ä»¬æ„å»ºäº†ä¸€ä¸ªæ ‡å‡†åŒ–çš„æ•°æ®é›†ï¼Œæ¶µç›–11ä¸ªä¸»è¦ä»»åŠ¡å’Œ560ä¸ªå…·æœ‰ä»£è¡¨æ€§çš„æ¯’æ€§åˆ†å­ï¼Œå¹¶è®¾è®¡äº†ä¸€ä¸ªæœºåˆ¶æ„ŸçŸ¥å’Œä»»åŠ¡è‡ªé€‚åº”çš„æç¤ºæ³¨é‡Šæµç¨‹ã€‚åŒæ—¶ï¼Œæå‡ºäº†è‡ªåŠ¨åŒ–è¯„ä¼°æ¡†æ¶ToxiEvalï¼Œæ•´åˆäº†æ¯’æ€§ç»ˆç‚¹é¢„æµ‹ã€åˆæˆå¯åŠæ€§ã€è¯ç‰©ç›¸ä¼¼æ€§å’Œç»“æ„ç›¸ä¼¼æ€§ï¼Œå½¢æˆé«˜é€šé‡è¯„ä¼°é“¾ã€‚å®éªŒç»“æœè¡¨æ˜ï¼Œå°½ç®¡å½“å‰çš„MLLMsåœ¨æ­¤ä»»åŠ¡ä¸Šä»é¢ä¸´é‡å¤§æŒ‘æˆ˜ï¼Œä½†å®ƒä»¬åœ¨æ¯’æ€§ç†è§£ã€è¯­ä¹‰çº¦æŸéµå¾ªå’Œç»“æ„æ„ŸçŸ¥åˆ†å­ç¼–è¾‘æ–¹é¢å¼€å§‹å±•ç°å‡ºæœ‰å¸Œæœ›çš„èƒ½åŠ›ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬æ–‡æ—¨åœ¨è§£å†³åˆ†å­æ¯’æ€§ä¿®å¤çš„å…·ä½“é—®é¢˜ï¼Œç°æœ‰æ–¹æ³•åœ¨ç³»ç»Ÿæ€§å®šä¹‰å’ŒåŸºå‡†åŒ–æ–¹é¢å­˜åœ¨ä¸è¶³ï¼Œå¯¼è‡´æ¯’æ€§ä¿®å¤æ•ˆæœä¸ä½³ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡çš„æ ¸å¿ƒæ€è·¯æ˜¯é€šè¿‡æ„å»ºToxiMolåŸºå‡†ä»»åŠ¡ï¼Œåˆ©ç”¨å¤šæ¨¡æ€å¤§è¯­è¨€æ¨¡å‹ï¼ˆMLLMsï¼‰è¿›è¡Œåˆ†å­æ¯’æ€§ä¿®å¤ï¼Œè®¾è®¡æœºåˆ¶æ„ŸçŸ¥çš„æç¤ºæ³¨é‡Šæµç¨‹ä»¥æé«˜ä¿®å¤æ•ˆæœã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šæ•´ä½“æ¶æ„åŒ…æ‹¬æ•°æ®é›†æ„å»ºã€æç¤ºæ³¨é‡Šæµç¨‹å’Œè‡ªåŠ¨åŒ–è¯„ä¼°æ¡†æ¶ToxiEvalï¼Œä¸»è¦æ¨¡å—æ¶µç›–æ¯’æ€§ç»ˆç‚¹é¢„æµ‹ã€åˆæˆå¯åŠæ€§ã€è¯ç‰©ç›¸ä¼¼æ€§å’Œç»“æ„ç›¸ä¼¼æ€§ã€‚

**å…³é”®åˆ›æ–°**ï¼šæœ€é‡è¦çš„æŠ€æœ¯åˆ›æ–°ç‚¹åœ¨äºé¦–æ¬¡æå‡ºäº†é’ˆå¯¹åˆ†å­æ¯’æ€§ä¿®å¤çš„æ ‡å‡†åŒ–åŸºå‡†ä»»åŠ¡ï¼Œå¹¶è®¾è®¡äº†æœºåˆ¶æ„ŸçŸ¥çš„æç¤ºæ³¨é‡Šæµç¨‹ï¼Œæ˜¾è‘—æå‡äº†ä¿®å¤çš„æœ‰æ•ˆæ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šå…³é”®è®¾è®¡åŒ…æ‹¬æ ‡å‡†åŒ–æ•°æ®é›†çš„æ„å»ºï¼Œæ¶µç›–å¤šç§æ¯’æ€§æœºåˆ¶ï¼Œæç¤ºæ³¨é‡Šæµç¨‹çš„æœºåˆ¶æ„ŸçŸ¥èƒ½åŠ›ï¼Œä»¥åŠè‡ªåŠ¨åŒ–è¯„ä¼°æ¡†æ¶çš„é«˜é€šé‡è¯„ä¼°é“¾ã€‚å…·ä½“å‚æ•°è®¾ç½®å’ŒæŸå¤±å‡½æ•°çš„é€‰æ‹©åœ¨å®éªŒä¸­è¿›è¡Œäº†è¯¦ç»†åˆ†æã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœæ˜¾ç¤ºï¼Œå°½ç®¡å½“å‰çš„MLLMsåœ¨åˆ†å­æ¯’æ€§ä¿®å¤ä»»åŠ¡ä¸Šä»é¢ä¸´æ˜¾è‘—æŒ‘æˆ˜ï¼Œä½†åœ¨æ¯’æ€§ç†è§£ã€è¯­ä¹‰çº¦æŸéµå¾ªå’Œç»“æ„æ„ŸçŸ¥åˆ†å­ç¼–è¾‘æ–¹é¢å±•ç°å‡ºä¸€å®šçš„æ½œåŠ›ï¼Œå…·ä½“æ€§èƒ½æå‡å¹…åº¦å°šæœªæ˜ç¡®ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬è¯ç‰©å¼€å‘ã€åŒ–å­¦åˆæˆå’Œç¯å¢ƒç§‘å­¦ç­‰ã€‚é€šè¿‡æœ‰æ•ˆçš„åˆ†å­æ¯’æ€§ä¿®å¤ï¼Œèƒ½å¤ŸåŠ é€Ÿæ–°è¯çš„ç ”å‘è¿›ç¨‹ï¼Œé™ä½è¯ç‰©å¼€å‘ä¸­çš„é£é™©ï¼Œå…·æœ‰é‡è¦çš„å®é™…ä»·å€¼å’Œæœªæ¥å½±å“ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Toxicity remains a leading cause of early-stage drug development failure. Despite advances in molecular design and property prediction, the task of molecular toxicity repair - generating structurally valid molecular alternatives with reduced toxicity - has not yet been systematically defined or benchmarked. To fill this gap, we introduce ToxiMol, the first benchmark task for general-purpose Multimodal Large Language Models (MLLMs) focused on molecular toxicity repair. We construct a standardized dataset covering 11 primary tasks and 560 representative toxic molecules spanning diverse mechanisms and granularities. We design a prompt annotation pipeline with mechanism-aware and task-adaptive capabilities, informed by expert toxicological knowledge. In parallel, we propose an automated evaluation framework, ToxiEval, which integrates toxicity endpoint prediction, synthetic accessibility, drug-likeness, and structural similarity into a high-throughput evaluation chain for repair success. We systematically assess nearly 30 mainstream general-purpose MLLMs and design multiple ablation studies to analyze key factors such as evaluation criteria, candidate diversity, and failure attribution. Experimental results show that although current MLLMs still face significant challenges on this task, they begin to demonstrate promising capabilities in toxicity understanding, semantic constraint adherence, and structure-aware molecule editing.

